Alexion Pharmaceuticals, Inc. ALXN
182.50 0.00 (+0.00%)
Apr 24, 2025, 3:47 PM EDT
180.21 Day range 182.67
52-week range unavailable
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2020 · select a line to chart its full history
Income statement
| Fiscal year | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 | FY 2017 Dec 31, 2017 | FY 2016 Dec 31, 2016 |
|---|---|---|---|---|---|
| 6.07B | 4.99B | 4.13B | 3.55B | 3.08B | |
| 5.52B | 4.60B | 3.76B | 3.10B | 2.83B | |
| 678.70M | 2.13B | 386.10M | 668.40M | 703.10M | |
| 603.40M | 2.40B | 77.60M | 443.30M | 399.40M | |
| 2.72 | 10.70 | 0.35 | 1.97 | 1.76 |
Balance sheet
| Fiscal year | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 | FY 2017 Dec 31, 2017 | FY 2016 Dec 31, 2016 |
|---|---|---|---|---|---|
| 2.96B | 2.69B | 1.37B | 584.40M | 966.00M | |
| 18.10B | 17.54B | 13.93B | 13.58B | 13.25B | |
| 6.45B | 6.27B | 4.77B | 4.69B | 4.56B | |
| 2.74B | 2.67B | 3.21B | 3.23B | 3.29B | |
| 11.65B | 11.27B | 9.17B | 8.89B | 8.69B |
Cash flow
| Fiscal year | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 | FY 2017 Dec 31, 2017 | FY 2016 Dec 31, 2016 |
|---|---|---|---|---|---|
| 3.00B | 2.08B | 426.00M | 1.12B | 1.09B | |
| -2.10B | 9.70M | 470.50M | -918.30M | -287.60M | |
| -611.90M | -739.10M | -102.40M | -596.60M | -836.20M | |
| -106.70M | -154.70M | -213.00M | -357.30M | -332.70M | |
| 311.00M | 1.36B | 782.90M | -381.60M | -44.10M |